CVS Health Corp (NYSE:CVS)’s traded shares stood at 10.09 million during the last session, with the company’s beta value hitting 0.55. At the close of trading, the stock’s price was $69.39, to imply an increase of 1.15% or $0.79 in intraday trading. The CVS share’s 52-week high remains $83.25, putting it -19.97% down since that peak but still an impressive 7.18% since price per share fell to its 52-week low of $64.41. The company has a valuation of $87.32B, with an average of 10.18 million shares over the past 3 months.

CVS Health Corp (NYSE:CVS) trade information

After registering a 1.15% upside in the last session, CVS Health Corp (CVS) has traded red over the past five days. The stock hit a weekly high of 71.66, jumping 1.15% in its intraday price action. The 5-day price performance for the stock is -0.50%, and -11.11% over 30 days. With these gigs, the year-to-date price performance is -12.12%.

CVS Health Corp (CVS) estimates and forecasts

Looking at statistics comparing CVS Health Corp share performance against respective industry, we note that the company has outperformed competitors. CVS Health Corp (CVS) shares are -3.64% down over the last 6 months, with its year-to-date growth rate higher than industry average at -4.81% against -14.10%.

CVS Dividends

CVS Health Corp has its next earnings report out in May. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. CVS Health Corp has a forward dividend ratio of 2.48, with the share yield ticking at 3.57% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.